Linnea’s Story

Hi!

I was 31 years old when I realized something was wrong. I had been losing weight — about 30 pounds, without trying — and people kept congratulating me.

Then came the extreme thirst, the constant trips to the bathroom, the muscle aches I chalked up to getting older.

When I finally tested my blood glucose at home, it read nearly 400 mg/dL.

My Blood Sugar was Dangerously High!

My A1C came back at 13%.

I had diabetes — though it would take years before I had the right diagnosis. My doctor assumed Type 2, which is what most doctors assume when presented with adult-onset diabetes.

I followed the advice: I took Metformin, changed my diet, added exercise. It helped at first, then stopped working. I tried a second medication. That stopped working too. No one told me that the reason my diabetes kept progressing wasn’t because I wasn’t trying hard enough — it was because I had the wrong diagnosis.

It wasn’t until I was referred to an endocrinologist, who ordered an autoantibody panel and a C-peptide test, that the real picture emerged: I had LADA diabetes, Latent Autoimmune Diabetes in Adults. My immune system had been quietly destroying my insulin-producing cells for years. Starting the right treatment — insulin — brought immediate relief. More than a decade later, I’ve achieved an A1C under 6% for the first time, and I manage my diabetes with an automated insulin pump and a CGM. I wrote Success with LADA Diabetes because I want to spare others the years of confusion, self-blame, and wrong treatment that I went through. If my story sounds familiar, you are not alone — and there is a clearer path forward.

Read the Book

Success with LADA Diabetes

The patient’s complete roadmap to Latent Autoimmune Diabetes in Adults — from screening and misdiagnosis through the “flaky pancreas” stage, insulin, technology, mental health, and the daily craft of managing diabetes well.

Get Success with LADA Diabetes on Amazon →

Privacy & Cookies: This site uses cookies. By continuing to use this website, you agree to their use. To find out more please see our Privacy Policy.